NX Prenatal's Convertible Note Round

NX Prenatal raised a round of funding on November 03, 2017.

NX Prenatal a molecular diagnostics company, develops diagnostic assays for adverse pregnancy conditions, such as preterm birth. Its portfolio includes NeXosome Preterm, a birth risk assay that detect…

Articles about NX Prenatal's Convertible Note Round: